Related Experiment Videos
A unified serotyping scheme for Moraxella bovis
1Department of Animal Health, University of Sydney, Camden, N.S.W., Australia.
Veterinary Microbiology
|September 1, 1991
Summary
This study classified Moraxella bovis isolates into seven serogroups using fimbrial antigens. Findings suggest limited global variation in these antigens, leading to an amalgamated serogroup classification.
Area of Science:
- Veterinary Microbiology
- Bacterial Pathogenesis
- Immunology
Background:
- Moraxella bovis is an important cause of infectious bovine keratoconjunctivitis (IBK).
- Fimbrial antigens of M. bovis are crucial for host-protective immunity and serological classification.
- Previous serological classifications have varied between regions.
Purpose of the Study:
- To classify international Moraxella bovis isolates into serogroups based on fimbrial antigens.
- To compare different serological methods for M. bovis classification.
- To propose an updated, amalgamated serogroup classification system.
Main Methods:
- Serological classification of 53 Australian, 7 British, 2 American, and 2 New Zealand M. bovis isolates.
- Utilized whole cell slide agglutination (SA), enzyme-linked immunosorbent assays (ELISA), and tandem-crossed immunoelectrophoresis (TCIE).
- Compared and reconciled discrepancies between SA and ELISA results using TCIE.
Main Results:
- Identified seven distinct serogroups based on fimbrial antigen variability.
- SA and ELISA yielded identical results for 68.7% of isolates, with TCIE resolving discrepancies.
- Results indicate potentially limited worldwide variation in M. bovis fimbrial antigens.
Conclusions:
- The study proposes an amalgamated classification of British and Australian M. bovis serogroups, designated A to G.
- A protocol for future serotyping of M. bovis is suggested.
- Limited global variation in fimbrial antigens may simplify vaccine development and epidemiological studies.